More than 150,000, new study shows.
Number of women living with MBC is increasing
The lack of robust epidemiological statistics on the number of people living with metastatic breast cancer (MBC) was highlighted as one of many critical gaps to making advances for MBC in our report, Changing the Landscape for People Living with Metastatic Breast Cancer.
Today, a new study led by Dr. Angela Mariotto of the National Cancer Institute (NCI), conducted in a partnership with the MBC Alliance, reports that as of January 1, 2017, more than 150,000 women in the US are living with MBC, 75% of whom have initially been diagnosed with an earlier stage of breast cancer and suffered a metastatic recurrence months to years later. The study also finds that median and five-year relative survival for women initially diagnosed with MBC is improving, especially among younger women.
Under the leadership of Musa Mayer, a long-time advocate for advanced breast cancer patients, in partnership with Alliance Chairman Marc Hurlbert, the MBC Alliance set out to develop the most accurate epidemiology information and statistics on the disease. Thanks to the hard work of NCI statisticians, today we have the best statistics on MBC currently available across the broad US population.
The study, entitled “Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States,” appears in the current issue of the journal Cancer Epidemiology, Biomarkers & Prevention. Since cancer registries in the United States, as in other countries around the world,…